page_banner

Fluorescence immunochromatography analyzer

Fluorescence immunochromatography analyzer

Short Description:

REF:PMDNC-02

Performance Parameter:Power requirements:AC220, 50Hz

Sample dosage:Whole blood/serum/plasma/peripheral blood/urine

Channels number:12

Printing mode: including thermal printer, Applies to external printer

Detection time( min):5-15min

Size:520*335*272mm

Applicable Department:laboratory, point-of-care, ICU/CCU


Product Detail

Product description

Intended Use:
PMDT 9000 Immunofluorescence Quantitative Analyzer is an analyzer for processing and analysis of PMDT test kits including markers for cardiovascular diseases, renal diseases, inflammation, fertility, diabetes mellitus, bone metabolism, tumor, and thyroid, etc. PMDT 9000 is used to measure concentration of biomarkers in human whole blood, serum, plasma or urine samples. The results can be used as an aid in clinical diagnosis of laboratory and point of care testing. It is applicable in Emergency, Clinical Lab, Outpatient, ICU, CCU, Cardiology, ambulance, operating room, wards, etc.

better designed POCT

more accurate POCT

steady structure for reliable results
auto alert to clean polluted cassettes
9’screen, manipulation friendly
various ways of data exporting
full IP of testing system and kits

high-precision testing parts
independent testing tunnels
temperature & humidity auto-control
auto QC and self-checking
reacting time auto-control
auto-saving data

more accurate POCT

more intelligent POCT

high-throughput for gargantuan testing needs
testing cassettes auto-reading
various testing samples available
fitting in many emergency situations
capable to connect printer directly (special model only)
registered QC for all testing kits

registered QC for all testing kits
real-time monitoring of every tunnels
touch-screen instead of mouse and keyboard
AI chip for data management

Steps for usage

step
step
step
step
step
step

application

promed (8)

Internal medicine Dept.

Cardiology / Hematology / Nephrology / Gastroenterology /Respiratory

Anti-coagulation and Anti-thrombotic management in patients with coronary heart disease, myocardial infarction and cerebral infarction.

Bleeding and coagulation monitoring in in patients with hemophilia, dialysis, renal failure, liver cirrhosis and gastrointestinal bleeding

promed (1)

Surgical Dept

Orthopedics / Neurosurgery / General surgery / Alcohol / Transplantation / Oncology

Coagulation monitoring in pre-, intra- and post-operation management

Evaluation of heparin neutralization

promed (2)

Transfusion Dept / Clinical laboratory Dept / Medical examination center

Guide the Component Transfusion

Improve the blood coagulation detection methods

Identify the high-risk thrombosis / bleeding cases

promed (3)

Interventional Dept

Cardiology Department / Neurology Department / Vascular Surgery Department

Monitoring of Interventional therapy, thrombolytic therapy

Monitoring of individualized antiplatelet therapy

Diagnostic items list

Category

Product name

Full name

Clinical solutions

Cardiac

 

DD

D-Dimer Rapid Test

Diagnosis of coagulation

NT-proBNP

NT-proBNP Rapid Test

Clinical diagnosis of heart failure

cTnI

cTnI Rapid Test

Highly sensitive and specific marker of myocardial damage

cTnI/Myo/CK-MB

cTnI/Myo/CK-MB Rapid Test

Highly sensitive and specific marker of myocardial damage

Lp-PLA2 Rapid Test

Lp-PLA2 Rapid Test

Marker of vascular inflammation and atherosclerosis

S100

S100 Rapid Test

Marker of blood–brain barrier (BBB) permeability and central nervous system(CNS) injury

ST2/NT-proBNP

ST2/NT-proBNP Rapid Test

Clinical diagnosis of heart failure

ST2

ST2 Rapid Test

Clinical diagnosis of heart failure

BNP

B-type natriuretic Rapid Test

Clinical diagnosis of heart failure

MYO

MYO Rapid Test

Sensitive marker for heart or muscle injury

CK-MB

CK-MB Rapid Test

Highly sensitive and specific marker of myocardial damage

Inflammation

PCT

Procalcitonin Rapid Test

Identification and diasnosis of bacterial infection,guiding the application of antibiotics

SAA

Serum Amyloid A Protein Rapid Test

Evaluation of inflammation

CRP

C Reactive Protein (hs-CRP+CRP) Rapid Test

Evaluation of inflammation

SAA/CRP

Serum Amyloid A Protein/C Reactive Protein (hs-CRP+CRP)  Rapid Test

Virus infection

IL-6

 IL-6 Rapid Test

Identification and diasnosis of inflammation and infection

Hormone

HCG

β-hCG Rapid Test

Assist in determining pregnancy

AMH

AMH Rapid Test

Evaluation the fertility

FSH *

FSH  Rapid Test

Assist in assessing ovarian health

INHB *

INHB Rapid Test

Marker of remaining fertility and ovarian function

Health

VB12 *

VB12 Rapid Test

Symptoms of vitamin B12 deficiency

VD *

25-OH Vitamin D Rapid Test

indicator of osteoporosis (bone weakness) and rickets (bone malformation)

N-MID

N-MID Rapid Test

Monitoring therapeutic treatments of Osteoporosis

Ferritin

Ferritin Rapid Test

Prediction of Iron deficiency anemia

Cancer

AFP

AFP Rapid Test

Marker of liver cancer serum

PSA *

Total Prostate Specific Antigen Determination Kit

Assist in the diagnosis of prostate cancer

CEA *

CEA Rapid Test

Assist in the diagnosis of colorectal cancer, pancreatic cancer, gastric cancer, breast cancer, medullary thyroid cancer, liver cancer, lung cancer, ovarian cancer, urinary system tumors

Thyroid

TSH *

TSH Rapid Test

Indicator for the diagnosis and treatment of hyperthyroidism and hypothyroidism and the study of the hypothalamic-pituitary-thyroid axis

T3 *

T3 Rapid Test

indicators for the diagnosis of hyperthyroidism

T4 *

T4 Rapid Test

indicators for the diagnosis of hyperthyroidism

PRL *

PRL Rapid Test

For pituitary microtumor, reproductive biology study

fT3 *

FT3 Rapid Test

fT4 *

FT4 Rapid Test

Gastric

PGI/PGII

Pepsinogen I, Pepsinogen II Rapid Test

Diagnosis of gastric mucosa injury

G17

Gastrin-17 Rapid Test

Gastric acid secretion, gastric health indicators

About Immunofluorescence

Immunofluorescence is a type of assay performed on biological samples to detect specific antigens in any biological specimen or sample and vice-versa. It was described in 1942 and refined by Coons in 1950, which used a fluorescence microscope able to read the specific immunological reaction and cellular slide preparations.

Principle of Immunofluorescence

Specific antibodies bind to the protein or antigen of interest.
Antibodies could be labeled with molecules that have the property of fluorescence (fluorochromes)
When light of one wavelength falls on fluorochrome, it absorbs that light to emit light of another wavelength.
The emitted light can be viewed with a fluorescence analyzer


  • Previous:
  • Next: